Patents by Inventor Christopher Bradbury

Christopher Bradbury has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11947344
    Abstract: A computer implemented method of operating a diagnostic instrument such that maintenance processes do not conflict with operator activity is presented. A maintenance process conflicts with operator activity if the probability of use of the diagnostic instrument is above a usage probability threshold. The probability of use of the diagnostic instrument is determined based on detected presence and/or movement of an operator in the proximity of the diagnostic instrument and/or operation of the diagnostic instrument.
    Type: Grant
    Filed: March 3, 2020
    Date of Patent: April 2, 2024
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Christopher Bradbury, Scott Perala
  • Publication number: 20200310395
    Abstract: A computer implemented method of operating a diagnostic instrument such that maintenance processes do not conflict with operator activity is presented. A maintenance process conflicts with operator activity if the probability of use of the diagnostic instrument is above a usage probability threshold. The probability of use of the diagnostic instrument is determined based on detected presence and/or movement of an operator in the proximity of the diagnostic instrument and/or operation of the diagnostic instrument.
    Type: Application
    Filed: March 3, 2020
    Publication date: October 1, 2020
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Christopher Bradbury, Scott Perala
  • Publication number: 20050009789
    Abstract: Nitroxyl is used to inhibit COX-2 activity and particularly to selectively inhibit COX-2 activity. Nitroxyl also is used to treat conditions that respond favorably to inhibition of COX-2 activity in subjects having such conditions. In some cases nitroxyl is used to treat conditions that respond favorably to inhibition of COX-2 activity in subjects having such conditions and who also have at least one other condition for which inhibition of COX-1 activity is disadvantageous. Nitroxyl can be provided directly, but typically is provided with the use of a nitroxyl donor. Nitroxyl donors include any agent or compound (or combination thereof) that donates HNO or NO?. Diazeniumdiolates are used in some cases as nitroxyl donors. In particular instances, diazeniumdiolates having a primary amine group are used as nitroxyl donors. Nitroxyl-donating compounds also are screened for selective COX-2 inhibition for identification as therapeutic agents.
    Type: Application
    Filed: May 12, 2004
    Publication date: January 13, 2005
    Inventors: David Wink, Katrina Miranda, Christopher Bradbury, David Gius, Jon Fukuto, Martin Feelisch